EuroClone S.p.A. Sustainability Profile
EuroClone S.p.A., headquartered in Italy, is a prominent player in the biotechnology and life sciences industry. Founded in 1983, the company has established itself as a leader in the development and distribution of innovative products and services for research and clinical applications. With a strong presence across Europe and beyond, EuroClone focuses on cell culture, molecular biology, and diagnostic solutions. The company’s core offerings include high-quality reagents, laboratory equipment, and advanced biotechnological tools, all designed to enhance research efficiency and accuracy. EuroClone's commitment to quality and innovation has earned it a respected position in the market, recognised for its contributions to scientific advancement. With a history of significant milestones, EuroClone continues to drive progress in the life sciences sector, supporting researchers and healthcare professionals worldwide.
DitchCarbon Score
How does EuroClone S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
EuroClone S.p.A.'s score of 30 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
EuroClone S.p.A., headquartered in Italy, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of AddLife AB (publ), and any emissions data or climate commitments may be inherited from this parent organization. As of now, EuroClone S.p.A. has not established specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of documented reduction targets suggests that the company may still be in the early stages of formalising its climate strategy. Given the lack of specific emissions data and reduction commitments, it is essential for EuroClone S.p.A. to consider developing a comprehensive climate action plan. This could include setting measurable targets for reducing Scope 1, 2, and 3 emissions, aligning with industry standards, and leveraging the sustainability initiatives of its parent company, AddLife AB (publ), to enhance its environmental performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 3,966,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 514,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 000,000,000 |
How Carbon Intensive is EuroClone S.p.A.'s Industry?
How Carbon Intensive is EuroClone S.p.A.'s Location?
EuroClone S.p.A.'s Scope 3 Categories Breakdown
EuroClone S.p.A.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2023, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 84% of Scope 3 emissions.
Top Scope 3 Categories
EuroClone S.p.A.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
EuroClone S.p.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
